National Health Services (NHS) patients across England are set to experience a significant enhancement in accessing key healthcare services such as
community nursing through the expansion of self-referral options that no longer require a GP appointment.
The recent announcement is part of the NHS primary care access recovery plan and is set to offer hundreds of thousands more individuals each month the opportunity
to refer themselves for essential services such as "incontinence support", "podiatry", or "hearing tests" without GP referrals.
This move aims to alleviate the burden on general practitioners through self-referrals for more than 180,000 patients, allowing them to focus their time and
resources on patients in need of immediate care and recover the long waiting times.
As per the NHS data, approximately 200,000 people per month self-refer themselves which under the new plan will extend to additional critical services tailored
to local population needs to "continue modernising GP, expand pharmacy services, and offer patients more choice in how they access care".
The Department of Health and Social Care (DHSC) published a notification regarding the shortage of Guanfacine 2mg and 3mg modified-release tablets has
raised concerns within the healthcare community.
This critical medicine supply notification, issued on March 28th, projects the unavailability of these tablets until the week commencing May 6, 2024.
Guanfacine tablets, commonly prescribed to alleviate symptoms of hyperactivity and impulsivity while enhancing attention and concentration, play a vital role in
managing conditions like attention deficit hyperactivity disorder (ADHD).
However, the scarcity of these specific strengths poses challenges for patients reliant on this medication.
Last year, several countries across the globe experienced shortages of medications for the treatment of attention deficit hyperactivity disorder (ADHD)including
the UK, the US and Australia.
Community Pharmacy England (CPE) has cautioned that while alternative strengths of Guanfacine remain accessible, they may not adequately meet the heightened demand,
potentially resulting in treatment interruptions for patients.
The Royal Pharmaceutical Society (RPS) has cautioned that measures to protect people against Covid-19 must be stepped up in the wake of discovery of the new variant, B.1.1.529.
It has urged members of the public to practice 'hands, face, space and ventilation' protection measures which have become less used in the last few months.
RPS director of pharmacy Robbie Turner said that though it was too early to conclude about the transmissibility or resistance of the new variant to current vaccines, quick action should be taken to protect the public.
"Each one of us must take the necessary precautions of wearing a mask in higher risk situations, maintaining social distancing wherever possible, ensuring there's appropriate ventilation indoors when meeting others and washing our hands regularly."
Encouraging people to take Covid vaccine, he said, it "is still our best defence against this virus".
Professor Sir Jonathan Van-Tam has announced that he will step down as deputy chief medical officer (DCMO) for England at the end of March to take up a new role at the University of Nottingham.
He joined Department of Health and Social Care (DHSC) on secondment from the university in 2017, and will soon return to be the pro-vice-chancellor for Faculty of
Medicine and Health Sciences.
Professor Van-Tam said: "My time as DCMO have been the most challenging of my professional career, especially the Covid response. We all wish Covid had never happened.
Notwithstanding, it has been the greatest privilege of my professional career to have served the people of the UK during this time.
"I want to pay tribute to Professor Chris Whitty, the CMO team, my fellow scientists, public health professionals and clinicians whose support, wisdom and energy has been inspiring.
"I will continue to work until the end of March and look forward to the next challenge."
As the DCMO for Health Protection, he has played key roles in various incidents, including domestic outbreaks of MERS and monkeypox, 2017 to 2018 influenza season
and during the Covid-19 pandemic.
A new legislation has been introduced to allow authorised pharmacists along with other healthcare professionals in Northern Ireland to certify 'fit notes',
health minister Robin Swann has announced.
Pharmacists and some other healthcare professionals in England, Scotland and Wales are already allowed to sign 'fit notes'.
Swann announced that 'fit notes' were also set to go fully digital in the future, meaning they would no longer need to be signed in ink.
He said: "I am delighted to introduce this legislation in Northern Ireland. This change will make it easier for people and employers to get the advice they need so
people can stay in work and will help free up doctors' time.
"Too often we see people being faced with unnecessary challenges to get a fit note. More professionals being able to offer this vital service will speed up the
process and support people to return to or remain in work."
The Department of Health and Social Care (DHSC) and NHS England last month issued a "safety critical" national patient safety alert, warning about
the UK-wide shortage of a life-saving drug used to treat patients with chronic breathing issues.
NHS trusts, health authorities, ambulance services, GP practices, private healthcare providers, and community pharmacy contractors were informed that
salbutamol 2.5mg and 5mg nebuliser liquid unit dose vials are in short supply, with the latter likely to remain "out of stock" until mid-April 2024.
As per the alert, the shortage of the drug resulted from a combination of manufacturing issues, leading to heightened demand for alternative suppliers.
It was mentioned that while terbutaline, salbutamol with ipratropium, and ipratropium nebuliser liquids remained available, they could't meet the increased demand.
Southwark Crown Court on Thursday sentenced two pharmacists to two years of imprisonment each, suspended for 24 months, after they were found guilty of
selling 'industrial' quantities of Class C controlled drugs.
Mandip Sidhu (47) of Littleover, Derby and Nabeil Nasr (42) of Cheadle, Greater Manchester, pleaded guilty at an earlier hearing following an investigation by
the Criminal Enforcement Unit of the Medicines and Healthcare Products Regulatory Authority (MHRA).
Both Sidhu and Nasr were pharmacists registered with the General Pharmaceutical Council at the time of the offenses, which took place between May 2013 and
June 2017. Sidhu was the director of Pharmaceutical Health Limited (PHL) in Derby, while Nasr owned several pharmacies across the North West of England.
Sidhu was sentenced to two years imprisonment on each of five counts of supplying Class C drugs and four months for forgery, all to run concurrently and suspended
for 24 months. Additionally, she must complete 200 hours of community service for her role in the illegal supply of diazepam, zolpidem, and zopiclone.
The Royal Pharmaceutical Society (RPS) has welcomed the Health Secretary Sajid Javid's plan to appoint Hormone Replacement Therapy (HRT) tsar to tackle the medicine shortages.
On Sunday (April 24) Sajid Javid told the Mail that he planned to tackle the problem (shortage of HRT medicine) by appointing a new HRT tsar with the role modelled on that of Kate Bingham, who successfully led the government's Covid vaccine taskforce.
"The difficulties in accessing HRT medicine have unfairly impacted women's mental health," said RPS President, Professor Claire Anderson.
"I look forward to working with this new champion for HRT and the Government on how we can better support women's health, building on the positive move to reduce
prescription charges for HRT for women."
Anderson also stressed that "the Government should now go further and end unfair prescription charges for patients in England altogether."
A pair of pharmacist brothers, who also own a popular restaurant in Kent, have started an innovative initiative 'Jabs with Kebabs' to encourage their community in England to come forward and take their Covid-19 vaccines.
Rav and Raj Chopra, who own V's Punjabi Grill, an Indian restaurant in Gravesend, established the walk-in vaccine site after their father, Jagtar Chopra, became unwell with Covid-19 last year.
The duo is among thousands to volunteer for the National Health Service (NHS) vaccine programme.
Talking to the PA news agency, Raj said he was inspired by the experience of his father, who got infected with the virus and has fully recovered since then.
"From a personal point of view, it was very debilitating to see Dad like that," said Raj Chopra. "It got everyone's emotions in play.
People infected with monkeypox can isolate at home if they remain well enough, whilst following measures to limit close contact with others, the UK's health
security agency (UKHSA) said on Monday (May 30), part of guidance designed to curb the country's rise in cases of the viral illness.
More than 300 suspected and confirmed cases of monkeypox have been reported in May, outside of Africa where the virus is endemic. The usually mild illness spreads
through close contact and can cause flu-like symptoms and pus-filled skin lesions.
An additional 71 cases of monkeypox have been identified in England, taking the total number of confirmed cases in the UK as a whole to 179 since early May.
Scientists are looking into what might explain the unusual surge of cases, given most are not linked to travel.
The UKHSA indicated community transmission was occurring in the UK and said infected people should avoid contact with others until their lesions have healed and
the scabs have dried off.
NHS England is rolling out a range of tech and data solutions, including an artificial intelligence (AI) system, across the health service to tackle winter
pressures.
The AI system will be used to identify patients at risk of hospital admission so community NHS teams can get to them first and reduce pressures on A&E departments.
On a trial basis, four GP practices in Somerset have started using the innovative technology which can highlight registered patients with complex health needs.
Health coaches, nurses, or GPs will then reach out to the people most at risk, and provide them with a range of preventive care such as monitoring, food parcels,
cleaning, shopping, as well as escalating care to specialist doctors.
Seven NHS trusts in England are set to begin trials of new wireless technologies to help improve patient care and strengthen connectivity in A&Es and
ambulance bays.
They have been awarded around £1 million as part of NHS England's Wireless Trials programme, which aims to leverage advanced wireless technologies to enhance
patient care and experiences while freeing up more staff time.
Manchester University NHS Foundation Trust will introduce an innovative approach of combining satellite and cloud-based wireless solutions to enhance connectivity
across its 10 hospital sites and wider community services.
At Mid Cheshire and Princess Alexandra Hospital NHS trusts, wireless trackers will be installed on medical equipment and hospital beds. This will allow real-time
monitoring and location tracking, enabling easy accessibility for staff to locate necessary items promptly.
The #AskAboutAsthma annual campaign, led by NHS England - London's Babies, Children and Young People programme, is returning for its eighth year with a
focus on promoting simple changes that can make a big difference to people living with asthma.
Scheduled to take place from 9-15 September, this year' campaign aims to address broader factors such as vaping, air quality, housing conditions, and mould to
ensure every child and young person in London with asthma receives the support and tools necessary to manage their condition effectively.
Pharmacists are encouraged to support the 2024 #AskAboutAsthma campaign, themed "helping children and young people with asthma to live their best lives." They
can contribute to the campaign in various ways, including:
Offering inhaler technique checks to all children and young people with asthma.
Identifying children and young people who are not regularly collecting their preventer medication and communicating this to their GP practice.
Identifying children and young people who are collecting large amounts of reliever medication and communicating this to their GP practice.
The National Health Service will begin its autumn Covid vaccine program next week, a month earlier than planned in response to the spread of a new variant
dubbed Pirola. Covid vaccines will be administered to care home residents and housebound individuals from Monday onwards, while over-65s and other vulnerable
groups will receive their appointments the week after.
On Aug. 30, NHS England shifted the autumn vaccination drive to start on September 11 in response to the new Covid-19 variant, BA.2.86, detected on August 18.
The primary groups can book through a national system upon receiving an invitation from the NHS. Some people may get an earlier call from their GP, and a few have
already scheduled Covid vaccinations alongside their flu jabs.
The NHS will begin inviting other eligible groups from Sept. 18. However, it is important to note that not everyone will receive a call at the same time. These
groups will include individuals aged 65 and over, those aged six months to 64 years in a clinical risk category, frontline health and social care workers, and
individuals aged 12 to 64 who are carers or household contacts of those with immunosuppression.
A new Attention-Deficit-Hyperactive disorder (ADHD) taskforce has been launched by National Health Services England (NHSE) to counter the challenges faced
by many suffering from the neurodevelopmental condition.
The ADHD taskforce aligns with the NHS Long Term Plan's vision to revolutionise mental health services, with a specific emphasis on bolstering community-based
care and reducing reliance on inpatient services.
The NHS has partnered with the government to tackle the escalating demands including increasing funding, improving system efficiency, altering the service
provision model, and clinical prioritisation by bringing together expertise from across a broad range of sectors, including the NHS, education and justice,
to help provide a joined-up approach in response to concerns around rising demand.
Over the past two decades, there has been a significant expansion in the acknowledgement and successful medical interventions for ADHD, leading to a steady
rise in clinical requests throughout the UK.
Responding to a new National Audit Office (NAO) report that indicated that NHS England's Long Term Workforce Plan (LTWP) needs improvements, the Royal
College of General Practitioners (RCGP) has expressed concerns that the plan may not adequately address the needs of GPs.
Published in June 2023, the workforce plan estimated that the NHS's health workforce will need to grow from 1.4m full-time equivalent (FTE) staff in 2021-22 to
between 2.3m and 2.4m FTE workers in 2036-37, an increase of 65 per cent to 72 per cent.
However, the NAO report highlighted that the workforce modelling has significant weaknesses, including a complex design; manual adjustments; optimistic future
assumptions and limited public communication of their uncertainty; and modelling outputs that could not be fully replicated.
To improve the modelling, the report recommended exploring the uncertainty of these assumptions and considering potential outcomes if they do not materialize as
expected. Additionally, it suggested including full integration of the different parts of the modelling pipeline to minimise manual adjustments.